Review
Open access
Sep 2026
Silencing with precision: In silico strategies for antisense oligonucleotide engineering
Therapeutics based on nucleic acids are emerging as a transformative drug class in the era of personalized medicine. They include antisense oligonucleotides (ASOs), aptamers, small interfering RNAs (siRNAs), small activating RNAs (saRNAs), microRNAs (miRNAs), and long non-coding RNAs (lncRNAs), in addition to messenger...
Abhigna Nagaraj, C. Kavana, Bhavana Harendra et al.
· Molecular Biology Reports · 0 citations